331
TITLE: Lack of evidence for a role of genetic variation in TMEM230 in the risk for Parkinson's disease in the Caucasian population  Full Text
AUTHORS: Giri, A; Mok, KY; Jansen, I; Sharma, M; Tesson, C; Mangone, G; Lesage, S; Bras, JM; Shulman, JM; Sheerin, UM; Diez Fairen, M; Pastor, P; Marti, MJ; Ezquerra, M; Tolosa, E; Correia Guedes, L; Ferreira, J ; Amin, N; van Duijn, CM; van Rooij, J; Uitterlinden, AG; Kraaij, R; Nalls, M; Simon Sanchez, J; ...More
PUBLISHED: 2017, SOURCE: NEUROBIOLOGY OF AGING, VOLUME: 50
INDEXED IN: Scopus WOS CrossRef: 23
332
TITLE: Medical treatment of parkinson’s disease
AUTHORS: Valadas, A; Ferreira, JJ ;
PUBLISHED: 2017, SOURCE: Movement Disorders Curricula
INDEXED IN: Scopus CrossRef
333
TITLE: Movement Disorders Curricula
AUTHORS: Cristian Falup Pecurariu; Joaquim Ferreira ; Pablo Martinez Martin; Kallol Ray Chaudhuri;
PUBLISHED: 2017, SOURCE: Movement Disorders Curricula
INDEXED IN: Scopus CrossRef: 5
334
TITLE: Mutations in TMEM230 are not a common cause of Parkinson's disease. <i>TMEM230</i>Mutations and PD  Full Text
AUTHORS: Quadri, M; Breedveld, GJ; Chang, HC; Yeh, TH; Guedes, LC; Toni, V; Fabrizio, E; De Mari, M; Thomas, A; Tassorelli, C; Rood, JPMA; Saddi, V; Chien, HF; Kievit, AJA; Boon, AJW; Stocchi, F; Lopiano, L; Abbruzzese, G; Cortelli, P; Meco, G; Cossu, G; Barbosa, ER; Ferreira, JJ ; Lu, CS; Bonifati, V; ...More
PUBLISHED: 2017, SOURCE: MOVEMENT DISORDERS, VOLUME: 32, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef: 13
335
TITLE: Neuromelanin Magnetic Resonance Imaging of the Substantia Nigra in LRRK2-Related Parkinson's Disease  Full Text
AUTHORS: Guedes, LC; Reimao, S; Paulino, P; Nunes, RG ; Bouca Machado, R; Abreu, D; Goncalves, N; Soares, T; Fabbri, M; Godinho, C; Lobo, PP; Neutel, D; Quadri, M; Coelho, M; Rosa, MM; Campos, J; Outeiro, TF; Sampaio, C; Bonifati, V; Ferreira, JJ ;
PUBLISHED: 2017, SOURCE: MOVEMENT DISORDERS, VOLUME: 32, ISSUE: 9
INDEXED IN: Scopus WOS CrossRef: 6
336
TITLE: New Perspectives on Study Designs for Evaluating Neuroprotection in Parkinson's Disease  Full Text
AUTHORS: Thibault, L; Rascol, O; Corvol, JC; Ferreira, J ; Defebvre, L; Deplanque, D; Bordet, R; Moreau, C; Devos, D;
PUBLISHED: 2017, SOURCE: MOVEMENT DISORDERS, VOLUME: 32, ISSUE: 10
INDEXED IN: Scopus WOS CrossRef: 12
337
TITLE: New therapeutic strategies in Huntington's disease  Full Text
AUTHORS: Ferreira, JJC ;
PUBLISHED: 2017, SOURCE: EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 24
INDEXED IN: WOS
338
TITLE: Occupational pesticide exposure and penetrance of LRRK2 Parkinson's disease (PD)  Full Text
AUTHORS: Tanner, C; Marras, C; Marder, K; Bressman, S; Alcalay, R; Saunders Pullman, R; Meng, CC; Gold Man, S; Korell, M; Luciano, MS; Tolosa, E; Schuele, B; Langston, JW; Brice, A; Mellick, G; Ferreira, J ; Tazir, M; Klein, C; Berg, D; Lang, A;
PUBLISHED: 2017, SOURCE: MOVEMENT DISORDERS, VOLUME: 32
INDEXED IN: WOS
340
TITLE: Opicapone for the management of end-of-dose motor fluctuations in patients with Parkinson's disease treated with L-DOPA
AUTHORS: Lees, AJ; Ferreira, J ; Rascol, O; Reichmann, H; Stocchi, F; Tolosa, E; Poewe, W;
PUBLISHED: 2017, SOURCE: EXPERT REVIEW OF NEUROTHERAPEUTICS, VOLUME: 17, ISSUE: 7
INDEXED IN: Scopus WOS CrossRef: 11
Page 34 of 70. Total results: 700.